Manufacturing · Profile from Manufacturing Research Companion: Companies, Strategic Moves, and Technical Studies
Chemours
The Wilmington, Delaware maker of titanium dioxide pigment, refrigerants and fluoropolymers that DuPont spun off on 1 Jul 2015 with most of the plants — Washington Works in West Virginia, Fayetteville Works in North Carolina, Chambers Works in New Jersey — where PFAS chemistry had been made or used for decades. Chemours' manufacturing story turns on a spin-off designed to carry liabilities, with capital and licence to operate not matched. It started life with ~$4bn of debt, a commodity pigment in a downturn and an indemnity to its former parent; it then built one of the world's two big franchises in low-global-warming refrigerants (Opteon), paid half of a ~$671m personal-injury settlement in 2017, signed a GenX consent order in North Carolina in 2019, sued DuPont over the spin, and settled into a 50/50 PFAS cost-sharing arrangement with DuPont and Corteva in Jan 2021. Between 2023 and 2026 it agreed its share of a $1.185bn water-system settlement, a New Jersey deal of $875m over 25 years and a North Carolina deal of $455m over 15 years — while an internal review in 2024 found that its CEO, CFO and controller had shifted cash flows between quarters to hit an incentive target. Its products are good businesses; its balance sheet carries the past.
At a glance
- Founded
- Spun off from DuPont 1 Jul 2015 (Shared facts list; section 21); the plants and products date to DuPont's fluorochemistry (1938–) and titanium dioxide (from the 1930s–40s, from memory, verify)
- Headquarters
- Wilmington, Delaware (from memory, verify)
- Ownership / structure
- Public (NYSE: CC)
- Leadership (2026)
- Denise Dignam, president and CEO (interim from 28–29 Feb 2024; permanent appointment reported by a secondary source, and named "President and CEO" in the Q3 2026 release); interim CFO in 2024 was Matt Abbott (8-K, reported; current CFO verify)
- Segments
- Titanium Technologies (Ti-Pure TiO2), Thermal & Specialized Solutions (Opteon and Freon refrigerants, foam blowing agents, propellants), Advanced Performance Materials (Teflon, Viton, Nafion, Krytox and other fluoropolymers and membranes) (segment names as reported in Q3 2026; brand allocation from memory, verify); Dignam referred in Q3 2026 to a "Performance Solutions" grouping (verify reporting structure)
- Scale
- Q3 2026 (release 2 Nov 2026): net sales ~$1.5bn (roughly flat y/y); adjusted net income $31m ($0.21 a share) vs $26m; adjusted EBITDA $200m vs $189m; Titanium Technologies adjusted EBITDA $85m (vs $25m); APM adjusted EBITDA $24m (+71%); TSS sales $510m (−9%); cash ~$613m, liquidity ~$1.6bn; Q4 2026 guide: sales −10–15% sequentially, adjusted EBITDA $130–160m (company and press, reported; one summary's GAAP net income of $196m is unreconciled, verify)
- Plants (US, selected)
- TiO2: DeLisle, Mississippi; New Johnsonville, Tennessee (from memory, verify); Altamira, Mexico. Fluoroproducts: Washington Works (Parkersburg, West Virginia); Fayetteville Works (North Carolina); Corpus Christi, Texas (Opteon, from memory, verify); Chambers Works (New Jersey; former site) (from memory, verify site list)
- Signature moves (incl. failures)
- Spin-off from DuPont (2015); the ~$671m PFOA MDL settlement (2017); the Opteon plant at Corpus Christi (2018); the Fayetteville GenX consent order (2019); the suit against DuPont and the 2021 MOU; the $1.185bn water-systems settlement (2023); the 2024 cash-flow review and CEO change; the New Jersey and North Carolina settlements (2025–26)
8 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2015
Spin Off from DuPont
Spin-off (from the parent's side, a separation; from Chemours' side, its creation)
2017
PFOA MDL Settlement
Product-liability settlement (personal-injury mass tort)
2018
Opteon Corpus Christi Plant
New plant (greenfield HFO-1234yf capacity) and product launch driven by regulation
2019
Fayetteville GenX Consent Order
Environmental case (state consent order) and process change (emission capture and treatment) — failure followed by remediation
2019
Suit Against DuPont and 2021 MOU
Regulatory or legal action (suit against the former parent) resolved by a liability-sharing contract
2023
Public Water Systems Settlement
Class settlement (PFAS drinking-water claims), jointly with DuPont and Corteva
2024
Cash Flow Review and CEO Change
Governance failure: internal review of cash-flow management, executive leave and leadership change
2025
New Jersey and North Carolina Settlements
State environmental settlements (natural-resource damages, site remediation, statewide PFAS and fraudulent-transfer claims)